AOAC SPADA Meeting

Defense Biological Product Assurance Office Presented to SPADA on October 17, 2018 SPADA- In Silico Analysis Standards for Assay Development

Shanmuga Sozhamannan, Technical Coordinator, DBPAO Joint Program Executive Officer for Chemical, Biological, Radiological and Nuclear Defense This work was funded by DUSA-TE and JPEO JPM Guardian, DBPAO

UNCLASSIFIED Distribution Statement A:Approved for public release; distribution isunlimited.

Why do we need a Standard for In Silico Analysis in Assay Development?

Exorbitant cost, time and effort for developing a new assay from scratch and improving/modifying an existing assay in response to signature erosion

2018_10_17_SPADA_Brief

2